Syncom Formulations India LtdPharmaceuticalsINE312C01025Consolidated₹20.02+1.22 (+6.49%)Jun-26
Valuation
Market Cap₹1.88K Cr
TTM PE21.30x
Forward PE19.76x
PEG3.79
Book Value₹4.41
P/B4.53x
TTM EPS₹0.94
Fwd EPS₹1.01
TTM Revenue₹497.80 Cr
TTM PAT₹85.53 Cr
TTM EBITDA₹87.84 Cr
TTM EBIT₹81.11 Cr
Last Qtr PAT₹24.85 Cr
Last Qtr EBITDA₹26.21 Cr
Last Qtr EBIT₹24.67 Cr
Profitability
ROE20.61%
ROCE27.43%
TTM NPM17.18%
TTM EBITDA %17.65%
Curr OPM18.63%
Last OPM16.78%
Curr NPM
Last NPM
Curr EPS₹0.26
Last EPS₹0.27
Balance sheet
Equity₹94.00 Cr
Reserve₹320.99 Cr
Total Debt₹1.47 Cr
D/E0.00x
Interest %0.97%
Curr Interest₹0.24 Cr
Price / range
Close₹20.02
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+6.49%
1W+2.61%
1M+28.58%
3M+43.10%
6M+67.53%
1Y+10.79%
2Y-13.67%
3Y+133.33%
5Y+229.82%
Diwali+41.89%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue124.66+7.0%134114.59121.44116.55486.57
Other Income7.8214.235.485.236.0230.97
Total Income132.48+8.1%148.23120.07126.67122.57517.54
Interest0.230.370.250.250.241.10
Expenditure-100.57+1.7%-115.36-95.03-104.31-102.35-417.05
PBDT000000
EBITDA25.86+63.9%21.4921.1718.7315.7877.15
Depreciation-1.54-2.48-1.36-1.35-1.34-6.53
EBIT24.32+68.4%19.0119.8117.3814.4470.62
PBT31.91+57.5%32.8625.0522.3620.26100.53
Tax-7.32-8.29-6.19-5.52-4.53-24.52
Equity9494009494
OPM24.0922.1721.8618.4116.5319.42
Net Profit24.59+56.3%24.5718.8616.8415.7376.01
NPM18.5616.5816.4613.8712.8314.69
EPS0.26+23.8%0.260.230.180.210.81

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue486.57+5.1%462.85+79.1%258.36+15.0%224.64+2.3%219.66-10.3%244.81
Other Income30.9717.1913.1014.6111.997.14
Total Income517.54+7.8%480.04+76.8%271.46+13.5%239.25+3.3%231.66-8.1%251.95
Expenditure-417.05-0.4%-415.39-73.3%-239.68-12.7%-212.70-3.5%-205.50+2.7%-211.27
Interest-1.10-0.85-4.45-3.13-1.36-0.27
PBDT000000
EBITDA77.15+44.2%53.50+92.1%27.85+42.0%19.61+0.7%19.47-48.6%37.85
Depreciation-6.53-5.19-4.72-4.54-3.95-4.04
EBIT70.62+46.2%48.31+108.9%23.13+53.5%15.07-2.9%15.52-54.1%33.81
PBT100.53+55.5%64.66+103.6%31.76+19.5%26.57+1.5%26.18-35.7%40.70
Tax-24.52-15.79-8.14-6.50-6.39-11.53
Equity94940000
OPM (%)19.4213.4712.0011.0011.0016.00
Net Profit76.01+55.5%48.87+106.9%23.62+17.7%20.07+1.4%19.79-32.2%29.17
NPM (%)14.6910.189.008.009.0012.00
EPS (Rs)0.81+42.1%0.57+78.1%0.32+33.3%0.24-7.7%0.26-31.6%0.38
CEPS0.810.570.320.240.240.37

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue125.53+7.4%135.41115.14121.72116.90489.17
Other Income7.8314.555.505.256.0331.34
Total Income133.36+8.5%149.97120.64126.97122.94520.51
Interest0.240.380.260.270.251.16
Expenditure-101.10+1.5%-116.26-95.55-104.93-102.69-419.43
PBDT000000
EBITDA26.21+65.9%22.0121.2118.4115.8077.43
Depreciation-1.54-2.48-1.36-1.35-1.34-6.53
EBIT24.67+70.6%19.5319.8517.0614.4670.90
PBT32.25+58.9%33.7025.0922.0420.29101.12
Tax-7.41-8.53-6.18-5.44-4.54-24.68
Equity9494009494
OPM24.1822.4720.8017.3616.5019.43
Net Profit24.85+57.8%25.1718.9116.6015.7576.44
NPM18.6316.7815.6713.0712.8114.69
EPS0.26+23.8%0.270.230.180.210.81

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 25-26FY 24-25FY 23-24
Revenue489.17+5.2%465.01+76.5%263.39
Other Income31.3417.4313.53
Total Income520.51+7.9%482.45+74.2%276.91
Expenditure-419.43-0.6%-416.94-71.6%-242.94
Interest-1.16-0.86-4.47
PBDT000
EBITDA77.43+43.1%54.12+82.6%29.64
Depreciation-6.53-5.19-4.72
EBIT70.90+44.9%48.93+96.3%24.92
PBT101.12+54.4%65.51+93.0%33.95
Tax-24.68-16.08-8.64
Equity94940
OPM (%)19.4313.5812.26
Net Profit76.44+54.6%49.43+95.3%25.31
NPM (%)14.6910.259.14
EPS (Rs)0.81+42.1%0.57+67.6%0.34
CEPS0.810.570.34

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

12
YearTypeAmountEx-Date
2026Final Dividend0.123 Sep 2026
2022Final Dividend0.0309 Sep 2022
2017Final Dividend0.0221 Sep 2017
2016Final Dividend0.0222 Sep 2016
2015Final Dividend0.0216 Sep 2015
2014Final Dividend0.0218 Sep 2014
2013Final Dividend0.610 Jul 2013
2012Final Dividend0.620 Sep 2012
2011Final Dividend0.522 Sep 2011
2010Final Dividend0.523 Sep 2010
2009Final Dividend0.524 Sep 2009
2008Final Dividend0.523 Sep 2008

Bonus

1
YearRatioEx-Date
20135:219 Aug 2013

Split

1
YearRatioEx-Date
2013Rs.10/- to Rs.1/-19 Aug 2013
Loading company dashboard...
Fetching ratios, charts, and peers